Cargando…

A phantom study to contrast and compare polymer and gold fiducial markers in radiotherapy simulation imaging

To assess visibility and artifact characteristics of polymer fiducials compared to standard gold fiducials for radiotherapy CT and MRI simulation. Three gold and three polymer fiducials were inserted into a CT and MRI tissue-equivalent phantom that approximated the prostate cancer radiotherapy confi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim Joon, Daryl, Smith, Drew, Tacey, Mark, Schneider, Michal, Harris, Benjamin, Ong, Wee Loon, Foroudi, Farshad, Jenkins, Trish, Wada, Morikatsu, Chao, Michael, Rykers, Kym, Khoo, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076319/
https://www.ncbi.nlm.nih.gov/pubmed/33903651
http://dx.doi.org/10.1038/s41598-021-88300-w
_version_ 1783684673709277184
author Lim Joon, Daryl
Smith, Drew
Tacey, Mark
Schneider, Michal
Harris, Benjamin
Ong, Wee Loon
Foroudi, Farshad
Jenkins, Trish
Wada, Morikatsu
Chao, Michael
Rykers, Kym
Khoo, Vincent
author_facet Lim Joon, Daryl
Smith, Drew
Tacey, Mark
Schneider, Michal
Harris, Benjamin
Ong, Wee Loon
Foroudi, Farshad
Jenkins, Trish
Wada, Morikatsu
Chao, Michael
Rykers, Kym
Khoo, Vincent
author_sort Lim Joon, Daryl
collection PubMed
description To assess visibility and artifact characteristics of polymer fiducials compared to standard gold fiducials for radiotherapy CT and MRI simulation. Three gold and three polymer fiducials were inserted into a CT and MRI tissue-equivalent phantom that approximated the prostate cancer radiotherapy configuration. The phantom and fiducials were imaged on CT and MRI. Images were assessed in terms of fiducial visibility and artifact. ImageJ was employed to quantify the pixel gray-scale of each fiducial and artifact. Fiducial gray-scale histograms and profiles were generated for analysis. Objective measurements of the contrast-to-noise ratio (CNR), signal-to-noise ratio (SNR), and artifact index (AI) were calculated. The CT images showed that the gold fiducials are visually brighter, with greater contrast than the polymer. The higher peak values illustrate this in the line profiles. However, they produce bright radiating and dark shadowing artifacts. This is depicted by the greater width of line profiles and the disruption of phantom area profiles. Quantitatively this results in greater percentile ranges of the histograms. Furthermore, for CT, gold had a higher CNR than polymer, relative to the phantom. However, the gold CNR and SNR were degraded by the greater artifact and thus AI. Both fiducials were visible on MRI and had similar histograms and profiles that were also reflected in comparable CNR, SNR and AI. Polymer fiducials were well visualized in a phantom on CT and MR and produce less artifact than the gold fiducials. Polymer markers could enhance the quality and accuracy of radiotherapy co-registration and planning but require clinical confirmation.
format Online
Article
Text
id pubmed-8076319
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80763192021-04-28 A phantom study to contrast and compare polymer and gold fiducial markers in radiotherapy simulation imaging Lim Joon, Daryl Smith, Drew Tacey, Mark Schneider, Michal Harris, Benjamin Ong, Wee Loon Foroudi, Farshad Jenkins, Trish Wada, Morikatsu Chao, Michael Rykers, Kym Khoo, Vincent Sci Rep Article To assess visibility and artifact characteristics of polymer fiducials compared to standard gold fiducials for radiotherapy CT and MRI simulation. Three gold and three polymer fiducials were inserted into a CT and MRI tissue-equivalent phantom that approximated the prostate cancer radiotherapy configuration. The phantom and fiducials were imaged on CT and MRI. Images were assessed in terms of fiducial visibility and artifact. ImageJ was employed to quantify the pixel gray-scale of each fiducial and artifact. Fiducial gray-scale histograms and profiles were generated for analysis. Objective measurements of the contrast-to-noise ratio (CNR), signal-to-noise ratio (SNR), and artifact index (AI) were calculated. The CT images showed that the gold fiducials are visually brighter, with greater contrast than the polymer. The higher peak values illustrate this in the line profiles. However, they produce bright radiating and dark shadowing artifacts. This is depicted by the greater width of line profiles and the disruption of phantom area profiles. Quantitatively this results in greater percentile ranges of the histograms. Furthermore, for CT, gold had a higher CNR than polymer, relative to the phantom. However, the gold CNR and SNR were degraded by the greater artifact and thus AI. Both fiducials were visible on MRI and had similar histograms and profiles that were also reflected in comparable CNR, SNR and AI. Polymer fiducials were well visualized in a phantom on CT and MR and produce less artifact than the gold fiducials. Polymer markers could enhance the quality and accuracy of radiotherapy co-registration and planning but require clinical confirmation. Nature Publishing Group UK 2021-04-26 /pmc/articles/PMC8076319/ /pubmed/33903651 http://dx.doi.org/10.1038/s41598-021-88300-w Text en © Crown 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Lim Joon, Daryl
Smith, Drew
Tacey, Mark
Schneider, Michal
Harris, Benjamin
Ong, Wee Loon
Foroudi, Farshad
Jenkins, Trish
Wada, Morikatsu
Chao, Michael
Rykers, Kym
Khoo, Vincent
A phantom study to contrast and compare polymer and gold fiducial markers in radiotherapy simulation imaging
title A phantom study to contrast and compare polymer and gold fiducial markers in radiotherapy simulation imaging
title_full A phantom study to contrast and compare polymer and gold fiducial markers in radiotherapy simulation imaging
title_fullStr A phantom study to contrast and compare polymer and gold fiducial markers in radiotherapy simulation imaging
title_full_unstemmed A phantom study to contrast and compare polymer and gold fiducial markers in radiotherapy simulation imaging
title_short A phantom study to contrast and compare polymer and gold fiducial markers in radiotherapy simulation imaging
title_sort phantom study to contrast and compare polymer and gold fiducial markers in radiotherapy simulation imaging
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076319/
https://www.ncbi.nlm.nih.gov/pubmed/33903651
http://dx.doi.org/10.1038/s41598-021-88300-w
work_keys_str_mv AT limjoondaryl aphantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT smithdrew aphantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT taceymark aphantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT schneidermichal aphantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT harrisbenjamin aphantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT ongweeloon aphantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT foroudifarshad aphantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT jenkinstrish aphantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT wadamorikatsu aphantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT chaomichael aphantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT rykerskym aphantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT khoovincent aphantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT limjoondaryl phantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT smithdrew phantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT taceymark phantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT schneidermichal phantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT harrisbenjamin phantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT ongweeloon phantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT foroudifarshad phantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT jenkinstrish phantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT wadamorikatsu phantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT chaomichael phantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT rykerskym phantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging
AT khoovincent phantomstudytocontrastandcomparepolymerandgoldfiducialmarkersinradiotherapysimulationimaging